Sirakova Tatiana D, Dubey Vinod S, Cynamon Michael H, Kolattukudy Pappachan E
Department of Biochemistry, Ohio State University, Columbus, Ohio 43210, USA.
J Bacteriol. 2003 May;185(10):2999-3008. doi: 10.1128/JB.185.10.2999-3008.2003.
Tuberculosis is one of the leading preventable causes of death. Emergence of drug-resistant tuberculosis makes the discovery of new targets for antimycobacterial drugs critical. The unique mycobacterial cell wall lipids are known to play an important role in pathogenesis, and therefore the genes responsible for their biosynthesis offer potential new targets. To assess the possible role of some of the genes potentially involved in cell wall lipid synthesis, we disrupted a mas-like gene, msl7, and a chalcone synthase-like gene, pks10, with phage-mediated delivery of the disruption construct, in which the target gene was disrupted by replacement of an internal segment with the hygromycin resistance gene (hyg). Gene disruption by allelic exchange in the case of each disruptant was confirmed by PCR and Southern blot analyses. Neither msl7 nor pks10 mutants could produce dimycocerosyl phthiocerol, although both could produce mycocerosic acids. Thus, it is concluded that these gene products are involved in the biosynthesis of phthiocerol. Both mutants were found to be attenuated in a murine model, supporting the hypothesis that dimycocerosyl phthiocerol is a virulence factor and thus the many steps involved in its biosynthesis offer potential novel targets for antimycobacterial therapy.
结核病是主要的可预防死因之一。耐多药结核病的出现使得发现抗分枝杆菌药物的新靶点至关重要。已知独特的分枝杆菌细胞壁脂质在发病机制中起重要作用,因此负责其生物合成的基因提供了潜在的新靶点。为了评估一些可能参与细胞壁脂质合成的基因的潜在作用,我们用噬菌体介导的破坏构建体破坏了一个mas样基因msl7和一个查耳酮合酶样基因pks10,其中通过用潮霉素抗性基因(hyg)替换内部片段来破坏靶基因。通过PCR和Southern印迹分析证实了每个破坏株中通过等位基因交换进行的基因破坏。尽管msl7和pks10突变体都能产生分枝菌酸,但两者都不能产生二霉菌酰基结核硬脂酸。因此,得出结论,这些基因产物参与结核硬脂酸的生物合成。在小鼠模型中发现这两种突变体都减毒,支持了二霉菌酰基结核硬脂酸是一种毒力因子的假设,因此其生物合成中涉及的许多步骤为抗分枝杆菌治疗提供了潜在的新靶点。